Progress at the Scientific Planning Committee

1638

Schermata 2014-03-07 alle 11.47.12

Established in 2011 as a key pillar of the EHDN’s strategic plan to improve its scientific governance and output, the Scientific Planning Committee (SPC)  has since developed clear goals and diverse competences.

Established in 2011 as a key pillar of the EHDN’s strategic plan to improve its scientific governance and output, the Scientific Planning Committee (SPC) has since developed clear goals and diverse competences.

The SPC currently comprises eight members who—as scientists, clinicians and representatives of industry and/or CHDI—all have in-depth knowledge of HD.

They are: Gillian Bates (King’s College London, UK), Jang Ho Cha (Merck & Co, USA), Alexandra Dürr (Hôpital de la Salpêtrière, France), Cheryl Fitzer-Attas (CHDI’s vice president of clinical research), Rainer Kuhn (cofounder of IRBM Promidis, Italy), Eldad Melamed (Sackler School of Medicine, Israel), Ignacio Muños-Sanjuan (CHDI’s vice president of translational biology) and Sarah Tabrizi (University College London, UK) (more information about the members is available on the SPC website).
The committee is supported by the EHDN’s intrinsic scientific framework, in particular by Bernhard Landwehrmeyer, Michael Orth and Juliana Bronzova of its Central Coordination, all of whom sit on the SPC, and by Danish Language Area Coordinator Mette Gilling Nielsen.

READ MORE 

Print Friendly, PDF & Email